Financhill
Back

Lantern Pharma Quote, Financials, Valuation and Earnings

This New Idea is Set to Shock the World

Click here to learn all the details.
Sell
32

LTRN
Lantern Pharma

Last Price:
4.08
Seasonality Move:
-0.83%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Nvidia?

Go here now for this breaking story.

Lantern Pharma Price Quote

$4.08
+0.06 (+1.49%)
(Updated: June 26, 2024 at 11:40 AM ET)

Lantern Pharma Key Stats

Sell
32
Lantern Pharma (LTRN) is a Sell

Day range:
$3.83 - $4.15
52-week range:
$2.38 - $11.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.21%

Volume:
64K
Avg. volume:
83.8K
1-year change:
-21.48%
Market cap:
$43.3M
Revenue:
$0
EPS:
$-1.63

How Much Does Lantern Pharma Make?

Data Unavailable

Is Lantern Pharma Growing As A Company?

Data Unavailable

Lantern Pharma Stock Price Performance

  • Did Lantern Pharma Stock Go Up Last Month?
    Lantern Pharma share price went down by -35.89% last month
  • Did LTRN's Share Price Rise Over The Last Year?
    LTRN share price fell by -21.48% over the past 1 year

What Is Lantern Pharma 52-Week High & Low?

Lantern Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Lantern Pharma?

  • How Much Debt Does Lantern Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Lantern Pharma Have?
    Cash and short term investments quarterly total is $38.4M
  • What Is Lantern Pharma’s Book Value Per Share?
    Book value per share is 3.32

Is Lantern Pharma Cash Flow Positive?

  • What Is LTRN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$13.7M
  • What Is Lantern Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$445.3K
  • What Is Lantern Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$525.5K

Lantern Pharma Return On Invested Capital

Data Unavailable

Lantern Pharma Earnings Date & Stock Price

Lantern Pharma Competitors

  • Who Are Lantern Pharma's Competitors?
    Below is a list of companies who compete with Lantern Pharma or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Lantern Pharma Dividend Yield

Data Unavailable

Lantern Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -18.61%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 22.00
Upside from Last Price: 447.26%

Major Shareholders

  • How many LTRN shares are owned by institutional investors?
    2.2M LTRN shares are owned by institutional investors
  • How many LTRN shares are owned by insiders?
    483.9K LTRN shares are owned by insiders